openPR Logo
Press release

The Global Alzheimer's Disease Therapeutics and Diagnostics Market to Progress with 5.56% of CAGR by 2028

12-07-2022 11:29 AM CET | Health & Medicine

Press release from: Triton Market Research

Alzheimer's Disease Therapeutics and Diagnostics Market

Alzheimer's Disease Therapeutics and Diagnostics Market

Triton Market Research presents the Global Alzheimer's Disease Therapeutics and Diagnostics Market report segmented by Therapeutics and Diagnostics (Therapeutics {Therapeutics by Drugs [Marketed Drugs, Pipeline Drugs], Therapeutics by Disease Stage [Late Stage: Severe AD, Early/Middle Stage: Mild to Moderate AD, Prodromal Stage], Therapeutics by Generic and Branded [Branded, Generic]}, Diagnostics {Lumbar Puncture Test, Positron Emission Tomography (PET), Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Blood Test, Other Diagnostics}) and by Geographical Region (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa), discussing Market Summary, Industry Outlook, Key Insights, Impact of COVID-19, Porter's Five Forces Analysis, Key Buying Impact Analysis, Industry Components, Different Phases Of Alzheimer's Disease, Market Attractiveness Index, Vendor Scorecard, Key Strategic Developments, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2021-2028).

Triton Market Research, in its report on the Global Alzheimer's Disease Therapeutics and Diagnostics Market, implies that this industry is expected to progress at a CAGR of 5.56% during the forecasting period (2021-2028).

Request Free Sample Report:
https://www.tritonmarketresearch.com/reports/alzheimers-disease-therapeutics-and-diagnostic-market#request-free-sample

As per estimates, nearly 5.8 million people in the United States have Alzheimer's dementia. By 2050, this number is expected to rise to 13.8 million. Thus, the growing prevalence of dementia in developing countries is a major factor that is expected to fuel the growth of the market in the coming years.

However, the failure of the late-stage drugs to induce significant improvement of symptoms and stringent regulations regarding drug development and clinical trials are hampering the market growth process.

The market in North America currently leads the global market, with the largest share. It is expected to continue its stronghold in the years to come.

There is a high population comprising elderly adults present in the region, who form a major patient base for dementia and Alzheimer's. This has led to an increased demand for AD therapeutics and diagnostics here.

Purchase our report:
https://www.tritonmarketresearch.com/reports/alzheimers-disease-therapeutics-and-diagnostic-market#purchase-option

Moreover, there are several research studies being conducted in the US for the development of novel therapeutics and diagnostics for the disease, which are being supported by new product launches. For instance, C2N Diagnostics launched PrecivityAD in November 2020, which is the world's first blood test to measure amyloid levels in the blood for Alzheimer's diagnosis. All these factors are anticipated to boost the studied market growth in the region.

Sun Pharmaceuticals Industries Ltd, Zydus Cadila, Allergan Plc acquired by Abbvie, Biogen Inc, Pfizer Inc, Teva Pharmaceutical Industries Limited, Luye Pharma Group, GE Healthcare, Eli Lilly & Company, Cognoptix Inc, Eisai Co Ltd, Amarantus Bioscience Holdings Inc, Siemens Healthineers AG, Novartis AG, F Hoffmann La Roche, Lupin Limited, Merck & Co Inc, Baxter International Inc, PeopleBio Co, and Johnson & Johnson are the eminent players present in this market.

The competition among players in this industry has increased significantly with the introduction of generics. Furthermore, this industry is also observing meaningful strategic collaborations among different players. For instance, Johnson & Johnson and GE Healthcare have formed entered into a partnership for a project that aims to find pre-symptomatic biomarkers for AD. Recent developments with respect to regulatory guidelines and disease biomarkers are expected to open new gateways for innovation in this field, which is expected to generate opportunities for new players to step into this market.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Alzheimer's Disease Therapeutics and Diagnostics Market to Progress with 5.56% of CAGR by 2028 here

News-ID: 2838220 • Views:

More Releases from Triton Market Research

Asia-Pacific Dermatology Devices Market Forecast 2023-2030: Trends and Growth Analysis
Asia-Pacific Dermatology Devices Market Forecast 2023-2030: Trends and Growth An …
The Asia-Pacific Dermatology Devices Market is experiencing significant growth, driven by increasing awareness and prevalence of skin disorders. Countries within this market include China, Japan, South Korea, India, Australia & New Zealand, ASEAN countries, and the Rest of Asia-Pacific. According to a research report by Triton, the market is expected to grow at a compound annual growth rate (CAGR) of 13.36% from 2023 to 2030. Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/asia-pacific-dermatology-devices-market#report-overview?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR
Future Insights: Middle East and Africa Dermatology Devices Market Forecast 2023-2030
Future Insights: Middle East and Africa Dermatology Devices Market Forecast 2023 …
The MIDDLE EAST AND AFRICA DERMATOLOGY DEVICES MARKET is poised for substantial growth, driven by the rising prevalence of skin disorders and increasing demand for advanced dermatological treatments. The market includes countries such as the United Arab Emirates, Saudi Arabia, Turkey, South Africa, and the Rest of the Middle East & Africa. According to Triton's research report, the dermatology devices market in this region is expected to advance at a
Expanding Scope of the Global Membranes Market in 2024-2032
Expanding Scope of the Global Membranes Market in 2024-2032
According to Triton's research report, the global membranes market generated $XX million in 2023 and is expected to generate a CAGR of 6.74% in revenue over the forecasting years 2024-2032. A recent study by Triton Market Research titled Global Membranes Market includes the Global Analysis and Forecasts by Material (Polymeric, Ceramic, Other Materials), Technology(Reverse Osmosis (RO), Nanofiltration (NF), Ultrafiltration (UF), Microfiltration (MF), Other Technologies), End-User (Utilities, Commercial, Industrial, Residential, Other End-Users),
Europe Synthetic Leather Market Size & Forecast to 2030
Europe Synthetic Leather Market Size & Forecast to 2030
Triton Market Research states that the Europe Synthetic Leather Market is poised for significant expansion, with an anticipated compound annual growth rate (CAGR) of 7.23% in revenue from 2023 to 2030. Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/europe-synthetic-leather-market#report-overview?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR This growth is driven by increasing consumer preference for cruelty-free and sustainable alternatives to genuine leather, as well as advancements in synthetic leather technology. Countries leading this market include Spain, Italy, France, Germany, the

All 5 Releases


More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from